Literature DB >> 30573505

Unrelated cord blood transplantation and post-transplant cyclophosphamide.

Andrea Bacigalupo1, Simona Sica2, Luca Laurenti2, Federica Sora'2, Sabrina Giammarco2, Elisabetta Metafuni2, Idanna Innocenti2, Francesco Autore2, Luciana Teofili2, Maria Bianchi2, Patrizia Chiusolo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30573505      PMCID： PMC6355502          DOI： 10.3324/haematol.2018.202598

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation.

Authors:  Rick Admiraal; Caroline A Lindemans; Charlotte van Kesteren; Marc B Bierings; A Birgitta Versluijs; Stefan Nierkens; Jaap Jan Boelens
Journal:  Blood       Date:  2016-10-04       Impact factor: 22.113

2.  A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database.

Authors:  N Kurita; M Gosho; Y Yokoyama; T Kato; N Obara; M Sakata-Yanagimoto; Y Hasegawa; N Uchida; S Takahashi; Y Kouzai; Y Atsuta; M Kurata; T Ichinohe; S Chiba
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

3.  Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party.

Authors:  Annalisa Paviglianiti; Jean Hugues Dalle; Mouhab Ayas; Jan Jaap Boelens; Fernanda Volt; Anna Paola Iori; Mair Pedro de Souza; Miguel Angel Diaz; Gerard Michel; Franco Locatelli; Charlotte Jubert; Ibrahim Yakoub-Agha; Henrique Bittencourt; Yves Bertrand; Chantal Kenzey; Karina Tozatto Maio; Hiromi Hayashi; Vanderson Rocha; Peter Bader; Eliane Gluckman; Annalisa Ruggeri
Journal:  Biol Blood Marrow Transplant       Date:  2017-12-27       Impact factor: 5.742

Review 4.  Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.

Authors:  Coco de Koning; Rick Admiraal; Stefan Nierkens; Jaap Jan Boelens
Journal:  Stem Cell Investig       Date:  2017-05-16

5.  One-unit versus two-unit cord-blood transplantation for hematologic cancers.

Authors:  John E Wagner; Mary Eapen; Shelly Carter; Yanli Wang; Kirk R Schultz; Donna A Wall; Nancy Bunin; Colleen Delaney; Paul Haut; David Margolis; Edward Peres; Michael R Verneris; Mark Walters; Mary M Horowitz; Joanne Kurtzberg
Journal:  N Engl J Med       Date:  2014-10-30       Impact factor: 91.245

6.  Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.

Authors:  Francesco Frassoni; Francesca Gualandi; Marina Podestà; Anna Maria Raiola; Adalberto Ibatici; Giovanna Piaggio; Mario Sessarego; Nadia Sessarego; Marco Gobbi; Nicoletta Sacchi; Myriam Labopin; Andrea Bacigalupo
Journal:  Lancet Oncol       Date:  2008-08-08       Impact factor: 41.316

7.  Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome.

Authors:  Gérard Michel; Claire Galambrun; Anne Sirvent; Cecile Pochon; Benedicte Bruno; Charlotte Jubert; Anderson Loundou; Ibrahim Yakoub-Agha; Noel Milpied; Patrick Lutz; Aude Marie-Cardine; Virginie Gandemer; Didier Blaise; Mauricette Michallet; Fanny Rialland; Cecile Renard; Claire Oudin; Sophie Esmiol; Mylene Seux; Karine Baumstarck; Mohamad Mohty; Vanderson Rocha; Jean-Hugues Dalle
Journal:  Blood       Date:  2016-04-20       Impact factor: 22.113

8.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

9.  Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; R F Duarte; C Dufour; A Gennery; N Kröger; J Kuball; F Lanza; S Montoto; A Nagler; J A Snowden; J Styczynski; M Mohty
Journal:  Bone Marrow Transplant       Date:  2017-03-13       Impact factor: 5.483

10.  GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes.

Authors:  Y-B Chen; T Wang; M T Hemmer; C Brady; D R Couriel; A Alousi; J Pidala; A Urbano-Ispizua; S W Choi; T Nishihori; T Teshima; Y Inamoto; B Wirk; D I Marks; H Abdel-Azim; L Lehmann; L Yu; M Bitan; M S Cairo; M Qayed; R Salit; R P Gale; R Martino; S Jaglowski; A Bajel; B Savani; H Frangoul; I D Lewis; J Storek; M Askar; M A Kharfan-Dabaja; M Aljurf; O Ringden; R Reshef; R F Olsson; S Hashmi; S Seo; T R Spitzer; M L MacMillan; A Lazaryan; S R Spellman; M Arora; C S Cutler
Journal:  Bone Marrow Transplant       Date:  2016-12-12       Impact factor: 5.483
View more
  6 in total

1.  Allogeneic stem cell transplantation with omidubicel in sickle cell disease.

Authors:  Suhag Parikh; Joel A Brochstein; Einat Galamidi; Aurélie Schwarzbach; Joanne Kurtzberg
Journal:  Blood Adv       Date:  2021-02-09

2.  Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.

Authors:  Scott R Solomon; Andrew St Martin; Mei-Jie Zhang; Karen Ballen; Asad Bashey; Minoo Battiwalla; Lee Ann Baxter-Lowe; Claudio Brunstein; Saurabh Chhabra; Miguel Angel Diaz Perez; Ephraim J Fuchs; Siddhartha Ganguly; Nancy Hardy; Peiman Hematti; Joseph McGuirk; Edward Peres; Olle Ringden; David Rizzieri; Rizwan Romee; Melhem Solh; David Szwajcer; Marjolein van der Poel; Edmund Waller; Basem M William; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2020-07-07       Impact factor: 5.742

3.  Optimizing cord blood selection.

Authors:  Annalisa Ruggeri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 4.  Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications.

Authors:  Patricia A Shi; Larry L Luchsinger; John M Greally; Colleen S Delaney
Journal:  Curr Opin Hematol       Date:  2022-08-29       Impact factor: 3.218

5.  Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.

Authors:  Giancarlo Fatobene; Vanderson Rocha; Andrew St Martin; Mehdi Hamadani; Stephen Robinson; Asad Bashey; Ariane Boumendil; Claudio Brunstein; Luca Castagna; Alida Dominietto; Hervé Finel; Yves Chalandon; Chantal Kenzey; Mohamed Kharfan-Dabaja; Hélène Labussière-Wallet; Jose M Moraleda; Rocco Pastano; Miguel-Angel Perales; Hanadi Rafii El Ayoubi; Annalisa Ruggeri; Anna Sureda; Fernanda Volt; Ibrahim Yakoub-Agha; Mei-Jie Zhang; Eliane Gluckman; Silvia Montoto; Mary Eapen
Journal:  J Clin Oncol       Date:  2020-02-07       Impact factor: 50.717

6.  Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning.

Authors:  John E Wagner; Karen K Ballen; Mei-Jie Zhang; Mariam Allbee-Johnson; Chatchada Karanes; Filippo Milano; Michael R Verneris; Mary Eapen; Claudio G Brunstein
Journal:  Blood Adv       Date:  2021-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.